loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 210326 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 FRESENIUS KABI USA (1)

filter

01 SOLUTION;INTRAMUSCULAR (1)

filter

01 RX (1)

filter

01 FULVESTRANT (1)

filter

01 No (1)

URL Supplier Web Content
SOLUTION; INTRAMUS...
250MG/5ML (50MG/ML...
2019-05-20
210326
FULVESTRANT
RX
No
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 210326

Looking for FDA Orange Book APPLICATION 210326 1

19

Fresenius Kabi USA, LLC, based in Austria, is a pharmaceutical company.

One of their notable products is FULVESTRANT, with a corresponding application number 210326.

Regulatory Information RX

With a dosage strength 250MG/5ML (50MG/ML)

Dosage Form Route SOLUTION; INTRAMUSCULAR

Reference Listed Drug No

Approved since 2019-05-20

Post Enquiry
POST ENQUIRY